ClinicalTrials.Veeva

Menu

Risk Factors for Residual Neoplasia After Endoscopic Mucosal Resection

V

Vitkovice Hospital

Status

Completed

Conditions

Colorectal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01478919
DDC VN 02

Details and patient eligibility

About

Laterally Spreading Tumors (LST) are important precursosrs of invasive colorectal cancer. Endoscopic treatment has replaced surgery in most of the cases. Nevertheless, after conventional Endoscopic Mucosal Resection (CER), Local Residual Neoplasia (LRN) is an issue. Therefore, endoscopic follow-up and treatment are necessary. To decrease its occurrence, the risk factors of LRN shoudl be identified. Thereafter, in high-risk patients, other modalities of initial treatment including Endoscopic Submucosal Dissection (ESD) and surgical treatment, could be considered. The purpose of this prospective study is to identify risk factors associated with the presence of LRN after CER of LSTs.

Enrollment

127 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all consecutive patients referred for EMR of LST

Exclusion criteria

  • polyposis syndromes
  • previous therapeutic attempt

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems